Jove
Visualize
Contact Us
JoVE
x logofacebook logolinkedin logoyoutube logo
ABOUT JoVE
OverviewLeadershipBlogJoVE Help Center
AUTHORS
Publishing ProcessEditorial BoardScope & PoliciesPeer ReviewFAQSubmit
LIBRARIANS
TestimonialsSubscriptionsAccessResourcesLibrary Advisory BoardFAQ
RESEARCH
JoVE JournalMethods CollectionsJoVE Encyclopedia of ExperimentsArchive
EDUCATION
JoVE CoreJoVE BusinessJoVE Science EducationJoVE Lab ManualFaculty Resource CenterFaculty Site
Terms & Conditions of Use
Privacy Policy
Policies

Filters

Soumitra Kar

Showing results (41-50 of 43) with videos related to

Pageof 5
Sort By:
You have reached the last page of results.This site can display upto 43 results.
The Lancet. Diabetes & Endocrinology|January 9, 2023
Insulin degludec versus insulin detemir, both in combination with insulin aspart, in the treatment of pregnant women with type 1 diabetes (EXPECT): an open‑label, multinational, randomised, controlled, non-inferiority trialElisabeth R Mathiesen, Amra Ciric Alibegovic, Rosa Corcoy, et al.
Nanoscale Advances|September 22, 2022
Nanodiamonds as a state-of-the-art material for enhancing the gamma radiation resistance properties of polymeric membranesAmita Bedar, Nitesh Goswami, Amit K Singha, et al.
Circulation|November 10, 2025
Coramitug, a Humanized Monoclonal Antibody for the Treatment of Transthyretin Amyloid Cardiomyopathy: a Phase 2, Randomized, Multicenter, Double-Blind, Placebo-Controlled TrialMarianna Fontana, Pablo Garcia-Pavia, Martha Grogan, et al.
Pageof 5

Showing results (41-50 of 43) with videos related to

Sort By:
Pageof 5
You have reached the last page of results.This site can display upto 43 results.
The Lancet. Diabetes & Endocrinology|January 9, 2023
Insulin degludec versus insulin detemir, both in combination with insulin aspart, in the treatment of pregnant women with type 1 diabetes (EXPECT): an open‑label, multinational, randomised, controlled, non-inferiority trialElisabeth R Mathiesen, Amra Ciric Alibegovic, Rosa Corcoy, et al.
Nanoscale Advances|September 22, 2022
Nanodiamonds as a state-of-the-art material for enhancing the gamma radiation resistance properties of polymeric membranesAmita Bedar, Nitesh Goswami, Amit K Singha, et al.
Circulation|November 10, 2025
Coramitug, a Humanized Monoclonal Antibody for the Treatment of Transthyretin Amyloid Cardiomyopathy: a Phase 2, Randomized, Multicenter, Double-Blind, Placebo-Controlled TrialMarianna Fontana, Pablo Garcia-Pavia, Martha Grogan, et al.
Pageof 5